C3 and COVID-19: Thus, increased C3a formation by the complement activation cascade in severe COVID-19 promotes differentiation of highly activated CD16+ cytotoxic T cells, which may display TCR-independent, antibody-dependent cellular cytotoxicity, and lead to vascular endothelial damage (226).